Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy

Thomas Wehler(University Medical Center of the Johannes Gutenberg University Mainz), Carl C. Schimanski(Johannes Gutenberg University Mainz)
International Journal of Colorectal Disease
September 15, 2012
10.1007/s00384-012-1551-2
Cited by 26

Related Papers

No related papers found

Powered by citation graph analysis